Here's Why Biotech ETFs Are Rallying Hard
ZACKS·2026-01-09 16:01
Key Takeaways Biotech rally fueled by cheap valuations, strong EPS growth and FDA approvals; IBB beats SPY.Fed rate cuts, easy funding & macro tailwinds favor high-growth biotech stocks.M&A surge, capital revival lift biotech ETFs like IBB, XBI, CANC & IDNA.Biotech stocks have rallied strongly into 2026, building on the late-2025 momentum from positive clinical data, cheaper valuation, easy money policy and favorable macro conditions. Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF (IBB) ...